NASDAQ : OMDA
Omada Health, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 18.73 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.15B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.10B |
| Enterprise Value | 878.96M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 61.22M |
| Shares Outstanding | 61.22M |
| Shares Change (YoY) | +433.19% |
| Shares Change (QoQ) | +8.53% |
| Owned by Insiders (%) | 2.50% |
| Owned by Institutions (%) | 81.33% |
| Float | 51.03M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 245.33 |
| Forward PE | 37.16 |
| PS Ratio | 3.70 |
| Forward PS | 3.10 |
| PB Ratio | 4.49 |
| P/TBV Ratio | 4.82 |
| P/FCF Ratio | 50.45 |
| P/OCF Ratio | 48.41 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 214.84 |
| EV / Sales | 2.99 |
| EV / EBITDA | 170.30 |
| EV / EBIT | n/a |
| EV / FCF | 40.70 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.91 |
| Quick Ratio | 3.70 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.17 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 1.84% |
| Return on Assets (ROA) | -0.09% |
| Return on Invested Capital (ROIC) | -0.12% |
| Return on Capital Employed (ROCE) | -0.18% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $327,441 |
| Profits Per Employee | $4,551 |
| Employee Count | 946 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 25.97 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | -25.23% |
| 50-Day Moving Average | 20.64 |
| 200-Day Moving Average | 17.70 |
| Relative Strength Index (RSI) | 41.52 |
| Average Volume (20 Days) | 991,130 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 8.35M |
| Short Previous Month | 7.45M |
| Short % of Shares Out | 13.63% |
| Short % of Float | 16.36% |
| Short Ratio (days to cover) | 5.58 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 309.76M |
| Gross Profit | 211.21M |
| Operating Income | -464,000 |
| Pretax Income | 4.31M |
| Net Income | 4.31M |
| EBITDA | 5.43M |
| EBIT | -464,000 |
| Earnings Per Share (EPS) | $0.07 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 221.71M |
| Total Debt | n/a |
| Net Cash | 221.71M |
| Net Cash Per Share | $3.62 |
| Equity (Book Value) | 252.74M |
| Book Value Per Share | 4.17 |
| Working Capital | 219.43M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 23.69M |
| Capital Expenditures | -960,000 |
| Depreciation & Amortization | 5.90M |
| Net Borrowing | -30.96M |
| Free Cash Flow | 22.73M |
| FCF Per Share | $0.37 |
Margins
| Measure | Value |
|---|
| Gross Margin | 68.19% |
| Operating Margin | -0.15% |
| Pretax Margin | 1.39% |
| Profit Margin | 1.39% |
| EBITDA Margin | 1.75% |
| EBIT Margin | -0.15% |
| FCF Margin | 7.34% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -433.19% |
| Shareholder Yield | -433.19% |
| Earnings Yield | 0.41% |
| FCF Yield | 1.98% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $28.17 |
| Price Target Difference | 56.67% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 23.68% |
| EPS Growth Forecast (3Y) | 71.56% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 7.97 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |